The evolution and development of insomnia pharmacotherapies
- PMID: 17824496
- PMCID: PMC1978321
The evolution and development of insomnia pharmacotherapies
Figures
References
-
- Sleep; National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults; June 13–15, 2005; 2005. pp. 1049–57. - PubMed
-
- Neubauer DN, Smith MT. Why treat insomnia? Prim Psychiatry. 2006;13:46–50.
-
- Richardson GS, Roehrs TA, Rosenthal L, Koshorek G, Roth T. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol. 2002;22:511–5. - PubMed
-
- Walsh JK. Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine. Sleep. 2004;27:1441–2. - PubMed
-
- Walsh JK, Roehrs TA, Roth T. Pharmacologic treatment of primary insomnia. In: Kryger MH, Roth T, Dement WC, editors. Principles and Practice of Sleep Medicine. Philadelphia, PA: Elsevier, Inc.; 2005. pp. 749–50.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical